BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8024676)

  • 1. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study.
    Hendrickse WA; Roffwarg HP; Grannemann BD; Orsulak PJ; Armitage R; Cain JW; Battaglia J; Debus JR; Rush AJ
    Neuropsychopharmacology; 1994 Apr; 10(2):85-91. PubMed ID: 8024676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoxetine on the polysomnogram in outpatients with major depression.
    Trivedi MH; Rush AJ; Armitage R; Gullion CM; Grannemann BD; Orsulak PJ; Roffwarg HP
    Neuropsychopharmacology; 1999 May; 20(5):447-59. PubMed ID: 10192825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-induced sleep disturbance in depressed patients.
    Dorsey CM; Lukas SE; Cunningham SL
    Neuropsychopharmacology; 1996 Jun; 14(6):437-42. PubMed ID: 8726754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fluoxetine on symptoms of insomnia in depressed patients.
    Satterlee WG; Faries D
    Psychopharmacol Bull; 1995; 31(2):227-37. PubMed ID: 7491373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Armitage R; Yonkers K; Cole D; Rush AJ
    J Clin Psychopharmacol; 1997 Jun; 17(3):161-8. PubMed ID: 9169959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
    Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
    Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prior fluoxetine treatment on EEG sleep in women with recurrent depression.
    Buysse DJ; Kupfer DJ; Cherry C; Stapf D; Frank E
    Neuropsychopharmacology; 1999 Aug; 21(2):258-67. PubMed ID: 10432474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients.
    Heiligenstein JH; Faries DE; Rush AJ; Andersen JS; Pande AC; Roffwarg HP; Dunner D; Gillin JC; James SP; Lahmeyer H
    Psychiatry Res; 1994 Jun; 52(3):327-39. PubMed ID: 7991725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone.
    el-Yazigi A; Chaleby K; Gad A; Raines DA
    J Clin Pharmacol; 1995 Jan; 35(1):17-21. PubMed ID: 7751409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
    Feige B; Voderholzer U; Riemann D; Dittmann R; Hohagen F; Berger M
    Neuropsychopharmacology; 2002 Feb; 26(2):246-58. PubMed ID: 11790520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fluoxetine and norfluoxetine concentrations and antidepressant response.
    Kelly MW; Perry PJ; Holstad SG; Garvey MJ
    Ther Drug Monit; 1989; 11(2):165-70. PubMed ID: 2785723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fluoxetine on sleep EEG in childhood depression: a preliminary report.
    Armitage R; Emslie G; Rintelmann J
    Neuropsychopharmacology; 1997 Oct; 17(4):241-5. PubMed ID: 9326748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients.
    Zhang B; Hao Y; Jia F; Tang Y; Li X; Liu W; Arnulf I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():85-92. PubMed ID: 23994660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine and oculomotor activity during sleep in depressed patients.
    Armitage R; Trivedi M; Rush AJ
    Neuropsychopharmacology; 1995 Apr; 12(2):159-65. PubMed ID: 7779244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REM sleep enhancement by bupropion in depressed men.
    Nofzinger EA; Reynolds CF; Thase ME; Frank E; Jennings JR; Fasiczka AL; Sullivan LR; Kupfer DJ
    Am J Psychiatry; 1995 Feb; 152(2):274-6. PubMed ID: 7840365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic sleep in recently remitted, elderly depressed patients in double-blind placebo-maintenance therapy.
    Lee JH; Reynolds CF; Hoch CC; Buysse DJ; Mazumdar S; George CJ; Kupfer DJ
    Neuropsychopharmacology; 1993 Feb; 8(2):143-50. PubMed ID: 8471126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, sleep, and antidepressants.
    Thase ME
    J Clin Psychiatry; 1998; 59 Suppl 4():55-65. PubMed ID: 9554322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.